A meningitis vaccine that is currently the subject of price negotiations should be introduced as soon as possible "to save lives", a charity has warned.
It is now a year since the body that advises the Department of Health on immunisation recommended the Bexsero MenB vaccine should be made available to children.
Discussions between the department and the drug company over the price of the vaccine began in August last year, following the advice from the Joint Committee on Vaccination and Immunisation (JCVI).
It said the vaccine should be offered to children at two, four and 12 months.
